Contraceptive pills induce an improvement in congenital hypoplasminogenemia in two unrelated patients with ligneous conjunctivitis
暂无分享,去创建一个
A. Girolami | S. Gavasso | L. Spiezia | A. Casonato | E. Pontara | G. Saggiorato | M. Sartori | D. Pellati
[1] P. Donshik,et al. Ligneous Conjunctivitis: Biochemical Evidence for Hypofibrinolysis , 2000, Inflammation.
[2] V. Marzinotto,et al. Effective treatment of ligneous conjunctivitis with topical plasminogen. , 2002, American journal of ophthalmology.
[3] U. Ozcelik,et al. Homozygous and Compound-heterozygous Type I Plasminogen Deficiency Is a Common Cause of Ligneous Conjunctivitis , 2001, Thrombosis and Haemostasis.
[4] P. Simioni,et al. State-of-the-Art-Review : Combined Heterozygous Plasminogen Deficiency and Factor V Leiden Defect in the Same Kindred , 2000, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[5] A. Girolami,et al. Familial Association of Hypoplasminogenemia and Heterozygous Factor V Deficiency , 1999, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[6] E. Stiehm,et al. Compound-heterozygous mutations in the plasminogen gene predispose to the development of ligneous conjunctivitis. , 1999, Blood.
[7] H. Schwarz,et al. Human homozygous type I plasminogen deficiency and ligneous conjunctivitis , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[8] H. Azuma,et al. Therapy with a purified plasminogen concentrate in an infant with ligneous conjunctivitis and homozygous plasminogen deficiency. , 1998, The New England journal of medicine.
[9] J. Fontcuberta,et al. Laboratory Evaluation and Clinical Characteristics of 2,132 Consecutive Unselected Patients with Venous Thromboembolism – Results of the Spanish Multicentric Study on Thrombophilia (EMET*-Study) , 1997, Thrombosis and Haemostasis.
[10] V. Schuster,et al. Homozygous mutations in the plasminogen gene of two unrelated girls with ligneous conjunctivitis. , 1997, Blood.
[11] P. Simioni,et al. “Pseudo Homozygous” Activated Protein C Resistance due to Double Heterozygous Factor V Defects (Factor V Leiden Mutation and Type I Quantitative Factor V Defect) Associated with Thrombosis: Report of Two Cases Belonging to Two Unrelated Kindreds , 1996, Thrombosis and Haemostasis.
[12] N. Heimburger,et al. Familiärer homozygoter und heterozygoter Typ I-Plasminogenmangel , 1996 .
[13] E. Holland,et al. Induction of ligneous conjunctivitis by conjunctival surgery. , 1995, American journal of ophthalmology.
[14] P. Roggenkämper,et al. Ligneous conjunctivitis. Ten years follow-up. , 1993, Ophthalmic paediatrics and genetics.
[15] H. Azuma,et al. Congenital plasminogen deficiency caused by a Ser572 to Pro mutation. , 1993, Blood.
[16] D. Stefanovic,et al. [Conjunctivitis lignosa and hydrocephalus (an unusual association of 2 diseases)]. , 1993, Vestnik oftalmologii.
[17] R. Tait,et al. Plasminogen Levels in Healthy Volunteers -Influence of Age, Sex, Smoking and Oral Contraceptives , 1992, Thrombosis and Haemostasis.
[18] T. Shigekiyo,et al. Danazol Therapy in Hypoplasminogenemia , 1992, Thrombosis and Haemostasis.
[19] A. Girolami,et al. Impaired release of tissue plasminogen activator (t‐PA) following DDAVP infusion in von Willebrand's disease with low platelet von Willebrand factor content , 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[20] Seymour R. Cohen. Ligneous Conjunctivitis: An Ophthalmic Disease with Potentially Fatal Tracheobronchial Obstruction , 1990, The Annals of otology, rhinology, and laryngology.
[21] E. Davie,et al. Characterization of the gene for human plasminogen, a key proenzyme in the fibrinolytic system. , 1990, The Journal of biological chemistry.
[22] M. Greaves,et al. Fibrinolysis during normal human pregnancy: complex inter‐relationships between plasma levels of tissue plasminogen activator and inhibitors and the euglobulin clot lysis time , 1988, British journal of haematology.
[23] B. Risberg,et al. Determination of plasminogen activator inhibitor in plasma using t-PA and a chromogenic single-point poly-D-lysine stimulated assay. , 1988, Thrombosis research.
[24] M. Alessi,et al. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. , 1988, Blood.
[25] P. Mannucci,et al. Congenital plasminogen deficiency associated with venous thromboembolism: therapeutic trial with stanozolol , 1986, British journal of haematology.
[26] D. Collen,et al. Assay of Human Tissue-Type Plasminogen Activator (t-PA) with an Enzyme-Linked Immunosorbent Assay (ELISA) Based on Three Murine Monoclonal Antibodies to t-PA , 1985, Thrombosis and Haemostasis.
[27] M. Boscaro,et al. Further Studies on the Hypercoagulable State of Patients with Cushing’s Syndrome , 1985, Thrombosis and Haemostasis.
[28] S. Manabe,et al. Homozygous protein C deficiency combined with heterozygous dysplasminogenemia found in a 21-year-old thrombophilic male. , 1985, Thrombosis research.
[29] F. Fabris,et al. The evaluation of factor VIII antigen by means of a simple slide test. , 1985, American journal of clinical pathology.
[30] R. Scarpa,et al. A ‘New’ Congenital Haemorrhagic Condition due to the Presence of an Abnormal Factor X (Factor X Friuli): Study of a Large Kindred , 1970, British journal of haematology.